FDA Adverse Event
Injury
Summary report: N
COMPLETE SE ILIAC
MDR report key: 3351522
·
Received September 17, 2013
Report
- Report Number
- 9612164-2013-00911
- Event Type
- Injury
- Date Received
- September 17, 2013
- Date of Event
- March 28, 2013
- Report Date
- September 4, 2013
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIO
- PMA / PMN Number
- P090006
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
EVALUATION RESULTS: INHERENT RISK OF PROCEDURE ¿ (STENOSIS). EVALUATION CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (STENOSIS). (B)(4).
Description of Event or Problem · 1
DURING INDEX PROCEDURE, THE PHYSICIAN USED ONE IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER TO TREAT A LESION LOCATED IN THE SFA TO POPLITEAL OF THE RIGHT LEG. THE TARGET LESION WAS DUE TO IN-STENT RESTENOSIS OF A PREVIOUSLY IMPLANTED COMPLETE SE STENT. THE STENOSIS EVENT WAS NOT ASSESSED FOR RELATEDNESS WITH DEVICE. COMPLETE SE IS UNDER IDE INVESTIGATION FOR SFA INDICATION. FOR PURPOSES OF MDR, COMPLETE SE SFA IS CONSIDERED THE SAME AS COMPLETE SE ILIAC.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 468889 | COMPLETE SE ILIAC | STENT, ILIAC | NIO | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00079 YR | Required Intervention | CLOPIDOGREL AND ASPIRIN |